摘要
目的对降压治疗妊娠期高血压疾病的安全性及有效性进行探讨。方法对2010年5月～2011年11月在本院就诊的100例妊娠期高血压患者的病例资料进行回顾性分析。通过随机方式将100例患者分为试验组和对照组,试验组患者40例,对照组患者60例。对照组接受传统常规降压药物进行治疗,试验组则通过静脉滴注和口服肼苯哒嗪及利血平等药物进行降压治疗。并对两组患者产后出血以及凝血功能情况进行及时的观察和记录。结果试验组40例患者经治疗后在产后出血以及凝血功能等方面均好于对照组,证明其治疗的安全性和有效性要好于传统方法。结论治疗妊娠期高血压疾病采用肼苯哒嗪、利血平等药物治疗效果较好,安全性高,值得应用。
Objective To explore the safety and validity of antihypertensive therapy in the treatment of gestational hyper- tension. Methods Clinical datas of 100 cases of gestational hypertension from May 2010 to November 2011 in our hospital was analyzed retrospectively. The 100 patients were divided into experimental group （40 cases） and control group （60 cases）. The 60 patients of control group were given conventional antihypertensive drugs treatment, the 40 patients of experimental group were given hydralazine intravenous or oral, and reserpine antihypertensive therapy. And postpartum hemor- rhage and blood clotting function of two groups were observed and recorded timely. Results After treatment, post-partum bleeding and clotting function of experimental group were better than that of control group. That proved its safety and efficacy of treatment was better than traditional methods. Conclusion The hyclralazine, reserpine and other drugs used in treatment of hypertensive disorders in pregnancy can improve the safety and efficacy, it is worthy of application.
出处
《中国当代医药》
2012年第28期191-192,共2页
China Modern Medicine
关键词
妊娠期
高血压
肼苯哒嗪
利血平
Gestation
Hypertension
Hydralazine
Reserpine
